Sign up to save your podcasts
Or
Share Changing the finish line: Syneos talks bringing payer, patient voice into drug development
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Changing the finish line: Syneos talks bringing payer, patient voice into drug development
The drug development “finish line” is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.
View all episodes
By William Reed LtdThe drug development “finish line” is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.